Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Muscular Dystrophy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06304064
What this trial is testing

Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)

Who this might be right for
Duchenne Muscular Dystrophy
Capricor Inc. 8
Not applicableLooking for participantsNCT04003363
What this trial is testing

The United Kingdom National Registry for Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy
Newcastle University 900
Not applicableUnknownNCT04967716
What this trial is testing

Genetics of Charcot-Marie-Tooth Dystrophy and Related Diseases

Who this might be right for
Peroneal Muscular Atrophy
Peking University Third Hospital 200
Large-scale testing (Phase 3)Ended earlyNCT03439514
What this trial is testing

ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

Who this might be right for
Dilated CardiomyopathyLamin A/C Gene Mutation
Pfizer 77
Not applicableUnknownNCT06378216
What this trial is testing

Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]

Who this might be right for
Myotonic Dystrophy 1
IRCCS Eugenio Medea 30
Not applicableStudy completedNCT01116570
What this trial is testing

Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Centre Hospitalier Universitaire de Saint Etienne 15
Large-scale testing (Phase 3)Ended earlyNCT05397470
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 260
Not applicableActive Not RecruitingNCT05072288
What this trial is testing

A Remote Physical Activity Program in the Population Suffering from Type 1 Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Université du Québec à Chicoutimi 40
Not applicableLooking for participantsNCT06094205
What this trial is testing

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

Who this might be right for
AnarthriaDysarthriaTetraplegia+5 more
Leigh R. Hochberg, MD, PhD. 2
Large-scale testing (Phase 3)Ended earlyNCT04371666
What this trial is testing

Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)

Who this might be right for
Duchenne Muscular Dystrophy
Kyntra Bio 98
Not applicableStudy completedNCT04616807
What this trial is testing

An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders

Who this might be right for
Myotonic Dystrophy
Lupin Ltd. 53
Not applicableStudy completedNCT04634682
What this trial is testing

Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Myogem Health Company, S.L. 30
Early research (Phase 1)Ended earlyNCT03362502
What this trial is testing

Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Pfizer 23
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07573631
What this trial is testing

An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
BioMarin Pharmaceutical 18
Not applicableStudy completedNCT03603171
What this trial is testing

Clinical Outcome Measures in Myotonic Dystrophy Type 2

Who this might be right for
Myotonic Dystrophy Type 2
Prof. Dr. Benedikt Schoser 60
Testing effectiveness (Phase 2)Looking for participantsNCT06131983
What this trial is testing

Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Sarepta Therapeutics, Inc. 60
Early research (Phase 1)Active Not RecruitingNCT06114056
What this trial is testing

A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)

Who this might be right for
Duchenne Muscular Dystrophy
West China Hospital 3
Testing effectiveness (Phase 2)Study completedNCT02667483
What this trial is testing

Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Daiichi Sankyo Co., Ltd. 8
Early research (Phase 1)Study completedNCT02530905
What this trial is testing

Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 12
Not applicableLooking for participantsNCT00272883
What this trial is testing

Molecular and Genetic Studies of Congenital Myopathies

Who this might be right for
Central Core DiseaseCentronuclear MyopathyCongenital Fiber Type Disproportion+5 more
Boston Children's Hospital 4,000
Next Page